Natural Alternatives Q2 net loss widens

Reuters

Feb 14

Natural Alternatives <a href="https://laohu8.com/S/QTWO">Q2</a> net loss widens

Overview

Nutritional supplements maker's Q2 fiscal 2026 revenue rose 2% yr/yr
Company reported a net loss of $2.6 mln for Q2 fiscal 2026

Outlook

Company anticipates net loss for second half and full fiscal 2026
NAI sees challenges in forecasting demand from multi-level marketing clients
Company anticipates net loss for full fiscal 2026 due to reduced customer forecasted sales along with delayed new product launches

Result Drivers

PRIVATE-LABEL SALES - Increased orders from existing and new customers drove a 2% rise in private-label contract manufacturing sales
CARNOSYN SALES - CarnoSyn beta-alanine sales rose 13% due to increased raw material orders, despite a decline in royalty and licensing revenue
FACTORY UTILIZATION - Losses attributed to underutilization of factory capacities despite improved gross margins and sales

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q2 Sales		$34.80 mln
Q2 Net Income		-$2.55 mln
Q2 Gross Profit		$2.49 mln
Q2 Operating Income		-$1.85 mln
Q2 Pretax Profit		-$2.33 mln

Press Release: ID:nGNX20Wvqh

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2611619588"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2611619588\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2611619588?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-14 05:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2611619588","market":"fut","top_or_hot":-1,"title":"Natural Alternatives Q2 net loss widens","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Natural Alternatives <a href=\"https://laohu8.com/S/QTWO\">Q2</a> net loss widens</title></head><body><p><span>Overview</span></p><ul><li><p>Nutritional supplements maker's Q2 fiscal 2026 revenue rose 2% yr/yr</p></li><li><p>Company reported a net loss of $2.6 mln for Q2 fiscal 2026</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company anticipates net loss for second half and full fiscal 2026</p></li><li><p>NAI sees challenges in forecasting demand from multi-level marketing clients</p></li><li><p>Company anticipates net loss for full fiscal 2026 due to reduced customer forecasted sales along with delayed new product launches</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>PRIVATE-LABEL SALES - Increased orders from existing and new customers drove a 2% rise in private-label contract manufacturing sales</p></li><li><p>CARNOSYN SALES - CarnoSyn beta-alanine sales rose 13% due to increased raw material orders, despite a decline in royalty and licensing revenue</p></li><li><p>FACTORY UTILIZATION - Losses attributed to underutilization of factory capacities despite improved gross margins and sales</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q2 Sales</p></td><td></td><td><p>$34.80 mln</p></td><td></td></tr><tr><td><p>Q2 Net Income</p></td><td></td><td><p>-$2.55 mln</p></td><td></td></tr><tr><td><p>Q2 Gross Profit</p></td><td></td><td><p>$2.49 mln</p></td><td></td></tr><tr><td><p>Q2 Operating Income</p></td><td></td><td><p>-$1.85 mln</p></td><td></td></tr><tr><td><p>Q2 Pretax Profit</p></td><td></td><td><p>-$2.33 mln</p></td><td></td></tr></tbody></table><p>Press Release: <span>ID:nGNX20Wvqh</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Natural Alternatives Q2 net loss widens</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNatural Alternatives Q2 net loss widens\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-14 05:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Natural Alternatives <a href=\"https://laohu8.com/S/QTWO\">Q2</a> net loss widens</title></head><body><p><span>Overview</span></p><ul><li><p>Nutritional supplements maker's Q2 fiscal 2026 revenue rose 2% yr/yr</p></li><li><p>Company reported a net loss of $2.6 mln for Q2 fiscal 2026</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company anticipates net loss for second half and full fiscal 2026</p></li><li><p>NAI sees challenges in forecasting demand from multi-level marketing clients</p></li><li><p>Company anticipates net loss for full fiscal 2026 due to reduced customer forecasted sales along with delayed new product launches</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>PRIVATE-LABEL SALES - Increased orders from existing and new customers drove a 2% rise in private-label contract manufacturing sales</p></li><li><p>CARNOSYN SALES - CarnoSyn beta-alanine sales rose 13% due to increased raw material orders, despite a decline in royalty and licensing revenue</p></li><li><p>FACTORY UTILIZATION - Losses attributed to underutilization of factory capacities despite improved gross margins and sales</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q2 Sales</p></td><td></td><td><p>$34.80 mln</p></td><td></td></tr><tr><td><p>Q2 Net Income</p></td><td></td><td><p>-$2.55 mln</p></td><td></td></tr><tr><td><p>Q2 Gross Profit</p></td><td></td><td><p>$2.49 mln</p></td><td></td></tr><tr><td><p>Q2 Operating Income</p></td><td></td><td><p>-$1.85 mln</p></td><td></td></tr><tr><td><p>Q2 Pretax Profit</p></td><td></td><td><p>-$2.33 mln</p></td><td></td></tr></tbody></table><p>Press Release: <span>ID:nGNX20Wvqh</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4533","symbol_name":"AQR资本管理(全球第二大对冲基金)","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nL1N3Z917X:1","article_id":"2611619588","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2611619588","pubTimestamp":1771018951,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Natural Alternatives Q2 net loss widensOverviewNutritional supplements maker's Q2 fiscal 2026 revenue rose 2% yr/yrCompany reported a net loss of $2.6 mln for Q2 fiscal 2026OutlookCompany anticipates ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","LU0154245673.USD":"BNP PARIBAS US MID CAP \"C\" (USD) INC","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","BK4183":"个人用品","BK4588":"碎股","BK4149":"建筑机械与重型卡车","BK4567":"ESG概念","BK4585":"ETF&股票定投概念","NAII":"Natural Alternatives Internation","LU0154245756.USD":"BNP PARIBAS US MID CAP \"C\" (USD) ACC","CMI":"康明斯"},"translate_title":"Natural Alternatives第二季度净亏损扩大","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NAII":0.9,"CMI":0.9},"content_text":"Natural Alternatives Q2 net loss widensOverviewNutritional supplements maker's Q2 fiscal 2026 revenue rose 2% yr/yrCompany reported a net loss of $2.6 mln for Q2 fiscal 2026OutlookCompany anticipates net loss for second half and full fiscal 2026NAI sees challenges in forecasting demand from multi-level marketing clientsCompany anticipates net loss for full fiscal 2026 due to reduced customer forecasted sales along with delayed new product launchesResult DriversPRIVATE-LABEL SALES - Increased orders from existing and new customers drove a 2% rise in private-label contract manufacturing salesCARNOSYN SALES - CarnoSyn beta-alanine sales rose 13% due to increased raw material orders, despite a decline in royalty and licensing revenueFACTORY UTILIZATION - Losses attributed to underutilization of factory capacities despite improved gross margins and salesKey DetailsMetricBeat/MissActualConsensus EstimateQ2 Sales$34.80 mlnQ2 Net Income-$2.55 mlnQ2 Gross Profit$2.49 mlnQ2 Operating Income-$1.85 mlnQ2 Pretax Profit-$2.33 mlnPress Release: ID:nGNX20WvqhFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}